Christos C. Zouboulis
Christos C. Zouboulis
Prof. Dr. med. Prof. honoraire Dr. h.c. - Dessau Medical Center, Brandenburg Medical School
Email verificata su - Home page
Citata da
Citata da
European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa
CC Zouboulis, N Desai, L Emtestam, RE Hunger, D Ioannides, I Juhász, ...
Journal of the European Academy of Dermatology and Venereology 29 (4), 619-644, 2015
New developments in our understanding of acne pathogenesis and treatment
I Kurokawa, FW Danby, Q Ju, X Wang, LF Xiang, L Xia, WC Chen, I Nagy, ...
Experimental dermatology 18 (10), 821-832, 2009
Acne and sebaceous gland function
CC Zouboulis
Clinics in dermatology 22 (5), 360-366, 2004
European evidence‐based (S3) guidelines for the treatment of acne
A Nast, B Dreno, V Bettoli, K Degitz, R Erdmann, AY Finlay, ...
Journal of the European Academy of Dermatology and Venereology 26, 1-29, 2012
Skin anti-aging strategies
R Ganceviciene, AI Liakou, A Theodoridis, E Makrantonaki, CC Zouboulis
Dermato-endocrinology 4 (3), 308-319, 2012
The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria
International Team for the Revision of the International Criteria for Behçet ...
Journal of the european Academy of Dermatology and Venereology 28 (3), 338-347, 2014
Prevalence, severity, and severity risk factors of acne in high school pupils: a community-based study
SZ Ghodsi, H Orawa, CC Zouboulis
Journal of investigative Dermatology 129 (9), 2136-2141, 2009
What is the pathogenesis of acne?
CC Zouboulis, A Eady, M Philpott, LA Goldsmith, C Orfanos, WJ Cunliffe, ...
Exp Dermatol 14, 143-152, 2005
Current use and future potential role of retinoids in dermatology
CE Orfanos, CC Zouboulis, B Almond-Roesler, CC Geilen
Drugs 53 (3), 358-388, 1997
Anti-TNF therapy in the management of Behçet's disease—review and basis for recommendations
PP Sfikakis, N Markomichelakis, E Alpsoy, S Assaad-Khalil, B Bodaghi, ...
Rheumatology 46 (5), 736-741, 2007
Epidemiological features of Adamantiades-Behcet’s disease in Germany and in Europe
CC Zouboulis, I Koetter, D Djawari, W Kirch, PK Kohl, FR Ochsendorf, ...
Yonsei Med J 38, 411-422, 1997
Sexual hormones in human skin
CC Zouboulis, WC Chen, MJ Thornton, K Qin, R Rosenfield
Hormone and metabolic research 39 (02), 85-95, 2007
Adalimumab for the treatment of moderate to severe hidradenitis suppurativa: a parallel randomized trial
AB Kimball, F Kerdel, D Adams, U Mrowietz, JM Gelfand, R Gniadecki, ...
Annals of internal medicine 157 (12), 846-855, 2012
Epidemiology of Adamantiades-Behçet's disease
CC Zouboulis
Annales de Medecine Interne 150, 488-498, 1999
Propionibacterium acnes and lipopolysaccharide induce the expression of antimicrobial peptides and proinflammatory cytokines/chemokines in human sebocytes
I Nagy, A Pivarcsi, K Kis, A Koreck, L Bodai, A McDowell, H Seltmann, ...
Microbes and infection 8 (8), 2195-2205, 2006
Epidemiology of Adamantiades-Behçet’s disease
Zierhut M, Ohno S (eds) Immunology of Behçet’s Disease, 1-16, 2003
Epidemiology of Adamantiades-Behçet's disease
CC Zouboulis
Annales de Medecine Interne 150, 488-498, 1999
Epidemiology of Adamantiades-Behcet's disease.
CC Zouboulis
Annales de Medecine Interne 150 (6), 488-498, 1999
Two phase 3 trials of adalimumab for hidradenitis suppurativa
AB Kimball, MM Okun, DA Williams, AB Gottlieb, KA Papp, CC Zouboulis, ...
New England Journal of Medicine 375 (5), 422-434, 2016
Establishment and characterization of an immortalized human sebaceous gland cell line (SZ95) 1
CC Zouboulis, H Seltmann, CE Orfanos, H Neitzel
Journal of Investigative Dermatology 113 (6), 1011-1020, 1999
Il sistema al momento non puň eseguire l'operazione. Riprova piů tardi.
Articoli 1–20